This site is intended for health professionals only

Published on 2 July 2007

Share this story:

RELATED ARTICLES
Antipsychotic use in dementia linked to more adverse outcomes than thought, study finds
No evidence of causal link between GLP-1 receptor agonists and suicide, says PRAC
Aripiprazole once-every-two-months long-acting injectable gains EU approval for schizophrenia
MHRA issues reminder on known risk of gambling disorder relating to aripiprazole
UK-wide consultation on treatment guidelines for alcohol dependence opens

European authorisation for schizophrenia drug

teaser

The European Commission has granted marketing authorisation for the atypical antipsychotic Invega



Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Oral vitamin A could become an alternative to isotretinoin for acne
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Stroke risk with AMD drug
Is oestrogen protective against COVID-19?
Ketogenic diet increases LDL cholesterol and risk of adverse cardiac event
Two-year data from clinical trial of HUMIRA®
Obstructed central venous catheters in haemodialysis

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x